Drug Shortage in Ireland: An In-depth Analysis of Current Situation, Causing factors, Impact and Future Recommendations.

Thumbnail Image
Paul, Riya
Issue Date
Research Projects
Organizational Units
Journal Issue
Alternative Title

Medicine shortages in Ireland strain the pharmaceutical industry and pharmacists. Pharmacists face increased workload and patient distress, leading to burnout risk. Solving medicine shortages is crucial to ensure continuous patient care and maintain the health sector's efficiency. It reduces the pressure on pharmacists, improves patient satisfaction, and stabilizes the pharmaceutical industry. Therefore, it's essential to address this issue promptly and effectively. This research work, titled "Drug Shortage in Ireland: An In-depth Analysis of Current Situation, Causing Factors, Impact, and Future Recommendations," aims to provide a comprehensive understanding of the ongoing drug shortage in Ireland, a country known as a hub for the pharmaceutical industry. Despite its significant role in global pharmaceutical production, Ireland grapples with the challenge of maintaining a steady supply of certain essential medicines. This study is steered by four primary objectives. Firstly, it aims to investigate the root causes of medicine shortages in Ireland. Secondly, it assesses the impact of these shortages on the healthcare sector and pharmaceutical industries. Thirdly, it identifies gaps and areas for improvement in the current approach towards managing and preventing shortages. Lastly, it proposes future recommendations and strategies for mitigating these medicine shortages. By addressing these objectives, the study hopes to offer insights that could guide policy decisions and contribute to ensuring a reliable supply of essential medicines for the Irish population. The research employed both quantitative and qualitative research approaches. It utilized an online survey questionnaire and phone call interviews to gather information from participants. The survey targeted healthcare professionals, primarily pharmacists, with an estimated sample size of 100. Of these, 74 responded, resulting in a response rate of 64%. Among the respondents, 53 were retail pharmacists, and 11 were clinical pharmacists across Ireland. The estimates sample size for the phone call interview was 6. Two of retail pharmacist responded and recorded the data. Additionally, the study's findings not only identified strategies to enhance supply chain resilience and improve patient access to essential medications but also offered insights to healthcare policymakers, administrators, and pharmacists to improve the current quality care. By examining causes, impact, and potential solutions, the study provides valuable guidance for improving the quality of care provided to patients.

PubMed ID